Abstract
Objective
To evaluate the imaging features of hepatic epithelioid hemangioendothelioma (HEH) on multiphasic CT, MR, and FDG-PET-CT.
Methods
Bi-institutional review identified 67 adults (mean age, 47 years; 23 M/44 F) with pathologically proven HEH and pretreatment multiphasic CT (n = 67) and/or MR (n = 30) and/or FDG-PET-CT (n = 13).
Results
HEHs were multifocal in 88% (59/67). Mean size of the dominant mass was 4.1 cm (range, 1.4–19 cm). The tumors were located in the peripheral, subcapsular regions of the liver in 96% (64/67). Capsular retraction was present in 81% (54/67 cases) and tumors were coalescent in 61% (41/67). HEH demonstrated peripheral ring enhancement on arterial phase imaging in 33% (21/64) and target appearance on the portal venous phase in 69% (46/67). Persistent peripheral enhancement on the delayed phase was seen in 49% (31/63). On MR, multilayered target appearance was seen on the T2-weighted sequences in 67% (20/30) and on the diffusion-weighted sequences in 61% (11/18). Target appearance on hepatobiliary phase of MRI was seen in 57% (4/7). On pre-therapy FDG-PET-CT, increased FDG uptake above the background liver parenchyma was seen in 62% (8/13).
Conclusion
HEHs typically manifest as multifocal, coalescent hepatic nodules in peripheral subcapsular location, with associated capsular retraction. Peripheral arterial ring enhancement and target appearance on portal venous phase are commonly seen on CT. Similarly, multilayered target appearance correlating with its histopathological composition is typically seen on multiple sequences of MR including T2-weighted, diffusion-weighted, and dynamic contrast-enhanced multiphasic MR.
Key Points
• Hepatic epithelioid hemangioendotheliomas manifest on CT and MR as multifocal, coalescent hepatic nodules in peripheral subcapsular location, with associated capsular retraction.
• Enhancement pattern on contrast-enhanced CT and MR can vary but peripheral ring enhancement on arterial phase and target appearance on portal venous phase are commonly seen.
• Retrospective two-center study showed that cross-sectional imaging may help in the diagnosis.
Similar content being viewed by others
Abbreviations
- CT:
-
Computed tomography
- FDG-PET-CT:
-
Fluoro-deoxy-glucose positron emission tomography
- HEH:
-
Hepatic epithelioid hemangioendothelioma
- HIPAA:
-
Health Insurance and Portability and Accountability Act
- MR:
-
Magnetic resonance imaging
References
Sardaro A, Bardoscia L, Petruzzelli MF, Portaluri M (2014) Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev 8:259
Woodall CE, Scoggins CR, Lewis AM, McMasters KM, Martin RC (2008) Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature. Am Surg 74:64–68
Mehrabi A, Kashfi A, Fonouni H et al (2006) Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 107:2108–2121
Uchimura K, Nakamuta M, Osoegawa M et al (2001) Hepatic epithelioid hemangioendothelioma. J Clin Gastroenterol 32:431–434
Makhlouf HR, Ishak KG, Goodman ZD (1999) Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 85:562–582
Taratuto AL, Zurbriggen G, Sevlever G, Saccoliti M (1988) Epithelioid hemangioendothelioma of the central nervous system. Immunohistochemical and ultrastructural observations of a pediatric case. Pediatr Neurosci 14:11–14
Studer LL, Selby DM (2018) Hepatic epithelioid hemangioendothelioma. Arch Pathol Lab Med 142:263–267
Mascarelli PE, Iredell JR, Maggi RG, Weinberg G, Breitschwerdt EB (2011) Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma. J Clin Microbiol 49:4006–4012
Mistry AM, Gorden DL, Busler JF, Coogan AC, Kelly BS (2012) Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma. J Gastrointest Cancer 43:521–525
Woller SC, Boschert ME, Hutson WR (2005) Hepatic epithelioid hemangioendothelioma presenting as liver infarction. Clin Gastroenterol Hepatol 3:xx
Walsh MM, Hytiroglou P, Thung SN et al (1998) Epithelioid hemangioendothelioma of the liver mimicking Budd-Chiari syndrome. Arch Pathol Lab Med 122:846–848
Fan F, Yang X, Zhu B, Zhang Y (2013) Clinical and radiological characteristics of Chinese patients with hepatic epithelioid hemangioendothelioma. Ann Saudi Med 33:334–338
Gan LU, Chang R, Jin H, Yang LI (2016) Typical CT and MRI signs of hepatic epithelioid hemangioendothelioma. Oncol Lett 11:1699–1706
Kim EH, Rha SE, Lee YJ, Yoo IeR, Jung ES, Byun JY (2015) CT and MR imaging findings of hepatic epithelioid hemangioendotheliomas: emphasis on single nodular type. Abdom Imaging 40:500–509
Lee JH, Jeong WK, Kim YK et al (2017) Magnetic resonance findings of hepatic epithelioid hemangioendothelioma: emphasis on hepatobiliary phase using Gd-EOB-DTPA. Abdom Radiol (NY) 42:2261–2271
Miller WJ, Dodd GD 3rd, Federle MP, Baron RL (1992) Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 159:53–57
Paolantonio P, Laghi A, Vanzulli A et al (2014) MRI of hepatic epithelioid hemangioendothelioma (HEH). J Magn Reson Imaging 40:552–558
Zhou L, Cui MY, Xiong J et al (2015) Spectrum of appearances on CT and MRI of hepatic epithelioid hemangioendothelioma. BMC Gastroenterol 15:69
Giardino A, Miller FH, Kalb B et al (2016) Hepatic epithelioid hemangioendothelioma: a report from three university centers. Radiol Bras 49:288–294
Ganeshan D, Szklaruk J, Kaseb A, Kattan A, Elsayes KM (2018) Fibrolamellar hepatocellular carcinoma: multiphasic CT features of the primary tumor on pre-therapy CT and pattern of distant metastases. Abdom Radiol (NY) 43:3340–3348
Lyburn ID, Torreggiani WC, Harris AC et al (2003) Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol 180:1359–1364
Mamone G, Miraglia R (2019) The “target sign” and the “lollipop sign” in hepatic epithelioid hemangioendothelioma. Abdom Radiol (NY) 44:1617–1620
Alomari AI (2006) The lollipop sign: a new cross-sectional sign of hepatic epithelioid hemangioendothelioma. Eur J Radiol 59:460–464
Dong Y, Wang WP, Cantisani V et al (2016) Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. World J Gastroenterol 22:4741–4749
Lin J, Ji Y (2010) CT and MRI diagnosis of hepatic epithelioid hemangioendothelioma. Hepatobiliary Pancreat Dis Int 9:154–158
Van Beers B, Roche A, Mathieu D et al (1992) Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr 16:420–424
Furui S, Itai Y, Ohtomo K et al (1989) Hepatic epithelioid hemangioendothelioma: report of five cases. Radiology 171:63–68
Giancipoli RG, Monti S, Basturk O et al (2018) Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: a CARE case report. Medicine (Baltimore) 97:e12795
Kitapci MT, Akkas BE, Gullu I, Sokmensuer C (2010) FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature. Ann Nucl Med 24:549–553
Suga K, Kawakami Y, Hiyama A, Hori K (2009) F-18 FDG PET/CT monitoring of radiation therapeutic effect in hepatic epithelioid hemangioendothelioma. Clin Nucl Med 34:199–202
Dong A, Dong H, Wang Y, Gong J, Lu J, Zuo C (2013) MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma. Clin Nucl Med 38:e66–e73
Kim R, Lee JM, Shin CI et al (2016) Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Eur Radiol 26:1808–1817
Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611
Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38:793–801
Mamone G, Marrone G, Caruso S et al (2015) Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase. Abdom Imaging 40:2313–2322
Funding
This study has received funding by MD Anderson Cancer Center Support Grant No. NIH/NCI P30 CA016672 from the National Cancer Institute, National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Khaled Elsayes.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• Retrospective
• Multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ganeshan, D., Pickhardt, P.J., Morani, A.C. et al. Hepatic hemangioendothelioma: CT, MR, and FDG-PET-CT in 67 patients—a bi-institutional comprehensive cancer center review. Eur Radiol 30, 2435–2442 (2020). https://doi.org/10.1007/s00330-019-06637-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-019-06637-3